English
Zydus Lifesciences Q4 Results
- BSE: 532321
- NSE: ZYDUSLIFE
- ISIN: INE010B01027
- Sector: Biotechnology & Drugs
BSE
924.35
-7.10 (-0.76%)
-7.10 (-0.76%)Volume31.99 K
Updated: Mon 8 Dec, 2025 | 15:57:55
NSE
924.60-6.85 (-0.74%)
-6.85 (-0.74%)Volume6.32 L
Updated: Mon 8 Dec, 2025 | 15:31:07
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Zydus Lifesciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 25 | Dec 24 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 4,820.50 | 4,293.10 | 12.28% | 4,113.90 | 17.18% |
| Depreciation/ Amortization | 237.90 | 229.00 | 3.89% | 205.30 | 15.88% |
| Operating Income | 1,707.40 | 976.00 | 74.94% | 1,419.90 | 20.25% |
| Net Income | 1,170.90 | 1,023.50 | 14.40% | 1,182.30 | -0.96% |
| Other Operating Expenses Total | 1,694.50 | 1,534.20 | 10.45% | 1,460.10 | 16.05% |
| Net Income Before Taxes | 1,672.00 | 1,184.10 | 41.20% | 1,547.00 | 8.08% |
| Total Revenue | 6,527.90 | 5,269.10 | 23.89% | 5,533.80 | 17.96% |
| Selling/ General/ Admin Expenses Total | 971.40 | 946.50 | 2.63% | 837.00 | 16.06% |
| Diluted Normalized EPS | 13.26 | 10.17 | 30.39% | 11.56 | 14.79% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.